大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/02/14 | 2,118 | 2,137 | 2,068 | 2,070 | -48 | -2.3% | 46,100 |
2018/02/13 | 2,269 | 2,283 | 2,113 | 2,118 | -158 | -6.9% | 140,600 |
2018/02/09 | 2,201 | 2,312 | 2,201 | 2,276 | -54 | -2.3% | 51,400 |
2018/02/08 | 2,359 | 2,359 | 2,313 | 2,330 | +9 | +0.4% | 44,700 |
2018/02/07 | 2,356 | 2,412 | 2,321 | 2,321 | +15 | +0.7% | 53,300 |
2018/02/06 | 2,370 | 2,384 | 2,248 | 2,306 | -141 | -5.8% | 93,800 |
2018/02/05 | 2,437 | 2,454 | 2,413 | 2,447 | -22 | -0.9% | 34,000 |
2018/02/02 | 2,502 | 2,506 | 2,459 | 2,469 | -20 | -0.8% | 20,600 |
2018/02/01 | 2,482 | 2,530 | 2,478 | 2,489 | +7 | +0.3% | 40,400 |
2018/01/31 | 2,477 | 2,522 | 2,469 | 2,482 | -16 | -0.6% | 27,600 |
2018/01/30 | 2,530 | 2,540 | 2,490 | 2,498 | ±0 | ±0% | 39,800 |
2018/01/29 | 2,531 | 2,598 | 2,494 | 2,498 | -14 | -0.6% | 62,200 |
2018/01/26 | 2,498 | 2,537 | 2,498 | 2,512 | +27 | +1.1% | 33,300 |
2018/01/25 | 2,543 | 2,543 | 2,481 | 2,485 | -48 | -1.9% | 34,800 |
2018/01/24 | 2,501 | 2,541 | 2,488 | 2,533 | +35 | +1.4% | 62,300 |
2018/01/23 | 2,520 | 2,562 | 2,484 | 2,498 | +2 | +0.1% | 109,200 |
2018/01/22 | 2,400 | 2,508 | 2,400 | 2,496 | +103 | +4.3% | 154,700 |
2018/01/19 | 2,377 | 2,405 | 2,363 | 2,393 | +16 | +0.7% | 61,900 |
2018/01/18 | 2,455 | 2,456 | 2,359 | 2,377 | -28 | -1.2% | 116,100 |
2018/01/17 | 2,408 | 2,422 | 2,376 | 2,405 | -3 | -0.1% | 34,900 |
2018/01/16 | 2,437 | 2,437 | 2,397 | 2,408 | -30 | -1.2% | 22,300 |
2018/01/15 | 2,461 | 2,466 | 2,411 | 2,438 | ±0 | ±0% | 32,300 |
2018/01/12 | 2,376 | 2,467 | 2,376 | 2,438 | +62 | +2.6% | 79,900 |
2018/01/11 | 2,382 | 2,385 | 2,352 | 2,376 | +4 | +0.2% | 30,300 |
2018/01/10 | 2,355 | 2,379 | 2,340 | 2,372 | +25 | +1.1% | 34,700 |
2018/01/09 | 2,357 | 2,365 | 2,341 | 2,347 | -6 | -0.3% | 27,600 |
2018/01/05 | 2,366 | 2,366 | 2,350 | 2,353 | -1 | ±0% | 31,700 |
2018/01/04 | 2,335 | 2,363 | 2,333 | 2,354 | -30 | -1.3% | 48,600 |
2017/12/29 | 2,379 | 2,413 | 2,365 | 2,384 | +23 | +1% | 68,600 |
2017/12/28 | 2,322 | 2,370 | 2,322 | 2,361 | +39 | +1.7% | 37,000 |
2017/12/27 | 2,290 | 2,329 | 2,290 | 2,322 | +28 | +1.2% | 18,700 |
2017/12/26 | 2,306 | 2,325 | 2,291 | 2,294 | -16 | -0.7% | 47,700 |
2017/12/25 | 2,314 | 2,326 | 2,303 | 2,310 | -16 | -0.7% | 39,100 |
2017/12/22 | 2,335 | 2,361 | 2,320 | 2,326 | -3 | -0.1% | 54,500 |
2017/12/21 | 2,327 | 2,333 | 2,317 | 2,329 | +5 | +0.2% | 35,400 |
2017/12/20 | 2,331 | 2,339 | 2,317 | 2,324 | -8 | -0.3% | 37,900 |
2017/12/19 | 2,332 | 2,343 | 2,328 | 2,332 | -6 | -0.3% | 51,900 |
2017/12/18 | 2,358 | 2,358 | 2,327 | 2,338 | -17 | -0.7% | 49,300 |
2017/12/15 | 2,387 | 2,387 | 2,346 | 2,355 | -16 | -0.7% | 44,500 |
2017/12/14 | 2,373 | 2,393 | 2,356 | 2,371 | +2 | +0.1% | 53,200 |
2017/12/13 | 2,377 | 2,389 | 2,363 | 2,369 | -8 | -0.3% | 49,900 |
2017/12/12 | 2,376 | 2,394 | 2,373 | 2,377 | -7 | -0.3% | 31,300 |
2017/12/11 | 2,375 | 2,394 | 2,375 | 2,384 | -5 | -0.2% | 32,200 |
2017/12/08 | 2,371 | 2,412 | 2,371 | 2,389 | -11 | -0.5% | 50,400 |
2017/12/07 | 2,428 | 2,446 | 2,400 | 2,400 | -11 | -0.5% | 42,600 |
2017/12/06 | 2,416 | 2,437 | 2,411 | 2,411 | -19 | -0.8% | 59,700 |
2017/12/05 | 2,451 | 2,453 | 2,425 | 2,430 | -52 | -2.1% | 53,000 |
2017/12/04 | 2,524 | 2,532 | 2,481 | 2,482 | -43 | -1.7% | 75,400 |
2017/12/01 | 2,518 | 2,565 | 2,518 | 2,525 | +12 | +0.5% | 59,900 |
2017/11/30 | 2,496 | 2,523 | 2,495 | 2,513 | +16 | +0.6% | 33,800 |
1801~
1850
件表示中 / 3984件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 30,000円 | +0.1% | -70.9% | 0.00% | 50.17倍 | 1.89倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステムリム | 30,500円 | - | - | 0.00% | - | 2.81倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
オンコリス | 61,700円 | +3771.0% | - | 0.00% | - | 5.59倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
Chordia | 21,200円 | - | - | 0.00% | - | 4.51倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
ステラファーマ | 39,900円 | +4.8% | - | 0.00% | - | 4.24倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
市場注目の銘柄
チャート関連のコラム